Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Pharmacovigilance01:19

Pharmacovigilance

876
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
876
Drug Elimination: The Concept of Clearance01:06

Drug Elimination: The Concept of Clearance

2.7K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
2.7K
Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Ethical Standards I01:25

Ethical Standards I

837
The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
837

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026
Same author

Elective genomic sequencing for adults in research, clinical and commercial contexts.

medRxiv : the preprint server for health sciences·2026
Same author

Public attitudes toward cascade genetic screening in the United States.

Health affairs scholar·2026
Same author

Multi-Omics Characterization of Human Molecular Responses to Spaceflight Across Two Independent Missions.

bioRxiv : the preprint server for biology·2026
Same author

Wastewater Surveillance to Inform Cancer Epidemiology and Evidence-Based Interventions.

Environmental science & technology·2026
Same author

Imagining Genomics and Population Health in 2050: Anticipating Future Research, Policy, and Governance Needs.

Public health genomics·2026
Same journal

A native sulfur deposit in Gale crater, Mars.

Science (New York, N.Y.)·2026
Same journal

Coordinated demise of harmful algal blooms.

Science (New York, N.Y.)·2026
Same journal

Genetic effects put into context.

Science (New York, N.Y.)·2026
Same journal

Bacteria share proteins to survive antibiotics.

Science (New York, N.Y.)·2026
Same journal

Impacts shaped Earth's first continents.

Science (New York, N.Y.)·2026
Same journal

Erratum for the Report "Covalently bonded single-molecule junctions with stable and reversible photoswitched conductivity" by C. Jia <i>et al</i>.

Science (New York, N.Y.)·2026
查看所有相关文章

相关实验视频

Updated: Jul 15, 2025

Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator
07:06

Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator

Published on: May 14, 2020

5.1K

在伦理上可以发射吗?

Vasiliki Rahimzadeh1, Jennifer Fogarty2, Timothy Caulfield3

  • 1Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.

Science (New York, N.Y.)
|September 28, 2023
PubMed
概括
此摘要是机器生成的。

人类航天研究需要明确的指导方针. 建立这些规则对于这个新兴领域的安全和道德行为至关重要.

更多相关视频

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

6.8K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

相关实验视频

Last Updated: Jul 15, 2025

Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator
07:06

Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator

Published on: May 14, 2020

5.1K
Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

6.8K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

科学领域:

  • 太空飞行研究
  • 人类在太空中的生理
  • 商业空间探索

背景情况:

  • 增加私营部门参与太空任务.
  • 在地球大气层之外对人类进行研究的独特挑战.
  • 目前缺乏商业载人航天研究的具体监管框架.

研究的目的:

  • 强调在商业航天中建立人类研究的监管框架的必要性.
  • 确定需要具体规则和指导方针的关键领域.
  • 倡导制定伦理和安全标准.

主要方法:

  • 审查现有的太空研究法规.
  • 对商业太空飞行中人类的潜在风险和伦理考虑的分析.
  • 对其他高风险研究环境中的监管方法进行比较研究.

主要成果:

  • 目前的法规对于商业航天的独特环境来说是不够的.
  • 参与者选择,知情同意,数据隐私和紧急协议需要具体的指导方针.
  • 在商业化的人类研究开始之前, 积极的监管方法至关重要.

结论:

  • 为了在商业航天中负责任地推进人类研究, 必须制定规则.
  • 制定这些法规将确保参与者的安全,数据完整性和伦理研究实践.
  • 国际合作可能有利于制定全面的指导方针.